# IMAX Corporation (IMAX) · Edgar & Edgarette company card

> Imax (IMAX) grew revenue 16.5% in FY2025 to $410 million, operating margin 20.5% against a 5.9% median for photographic equipment & supplies, equity 37.8% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 921582 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/IMAX) · [JSON](https://www.pops4.com/boards/company/IMAX.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $410M |
| Revenue growth, 1 year | 16.5% |
| Revenue growth per year | 12.6% |
| Operating margin | 20.5% (prior year 12.5%) |
| Net margin | 11.1% |
| Operating cash flow | $127M |
| Capital spending | $8M |
| Free cash flow | $119M |
| Cash | $151M |
| Long-term debt | — |
| Total assets | $894M |
| Total equity | $338M |
| Equity ÷ assets | 37.8% |
| Return on equity | 13.5% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Piotroski F: 7 of 9 (solid)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $410.2M (FY2025). Experience: revenue up 16.5% on the year, up 12.6% a year over 4 years; operating margin 20.5%, up from 12.5%. Soundness: equity 37.8% of assets, return on equity 13.5%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $379.6M and $551.2M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $345.4M to $608.0M. A statistical range, not company guidance. Against peers (147 filers, $50M+ revenue, its industry group): operating margin 20.5% against a 5.9% median; growth 16.5% against 7.9%.

Range logged 2026-10-31, receipt 3e999ebd0f30e551, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-08-21 ([filing](https://www.sec.gov/Archives/edgar/data/921582/000162828026058427/0001628280-26-058427-index.htm))

## Recent filings

- 8-K · filed 2026-08-21 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/921582/000162828026058427/0001628280-26-058427-index.htm)
- 10-Q · filed 2026-07-23 · [filing](https://www.sec.gov/Archives/edgar/data/921582/000162828026049300/0001628280-26-049300-index.htm)
- 8-K · filed 2026-07-23 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/921582/000162828026049290/0001628280-26-049290-index.htm)
- 8-K · filed 2026-06-11 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/921582/000162828026042508/0001628280-26-042508-index.htm)
- 10-Q · filed 2026-04-30 · [filing](https://www.sec.gov/Archives/edgar/data/921582/000162828026028960/0001628280-26-028960-index.htm)
- 8-K · filed 2026-04-30 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/921582/000162828026028907/0001628280-26-028907-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000921582.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=921582

## Cite

POPS4, Edgar & Edgarette: IMAX Corporation (IMAX) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/IMAX. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.